-
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages
Source: Buzz FX / 08 Feb 2025 03:06:10 America/Chicago
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages Written by MarketBeat February 8, 2025 Share Link copied to clipboard. Shares of Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) have received an
Read more...